Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 93 citations
Open access — free full text available
Open access
Electronic publication date
October 22, 2013

View on Pubmed.gov 23786162 | View on doi.org 10.1111/febs.12... | View the free full text Full text

microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.

Search for publications in this journal FEBS J - 280(16):3962-74

  • Wenjing Cui

    Search for this expert
    1
  • Shuai Zhang

    Search for this expert
  • Changliang Shan

    Search for this expert
  • Li Zhou

    Search for this expert
  • Zhemin Zhou

    Search for this expert
    Contact the corresponding author.
    Reported by OpenAlex: verify on the publication before relying on it.

Abstract

microRNAs are small, highly conserved, non-coding RNAs that regulate gene expression of target mRNAs through cleavage or translational inhibition, and are widely involved in carcinogenesis and cancer development. In this study, the expression profile of microRNA-133a (miR-133a) was examined in breast cancer cells and breast cancer tissues. The results showed that expression of miR-133a in both breast cancer cells and breast cancer tissues was significantly down-regulated. Over-expression of miR-133a in tumor cells arrested the cell cycle by drastically decreasing the G2 /S phase and retarded the newly synthesized DNA, suggesting a regulatory role for miR-133a in proliferation of breast cancer cells. Bioinformatics prediction showed that epidermal growth factor receptor (EGFR) is a potential target for miR-133a. A dual luciferase reporter gene assay showed that miR-133a bound to the 3' UTR of EGFR but not a mutated 3' UTR, thereby down-regulating the protein expression level. Accordingly, we found that expression of EGFR protein decreased with increased expression of miR-133a in MCF-7 and MDA-MB-231 cells. Over-expression of miR-133a in breast cancer cells resulted in suppression of the level of phosphorylated Akt protein (p-Akt) and inhibition of p-Akt nuclear translocation. These results demonstrate that miR-133a, which may act as a tumor suppressor in breast cancer, regulates the cell cycle and proliferation in tumorigenesis by targeting EGFR through the downstream signal molecule Akt. Overall, these results show that miR-133a may be used as biomarker and/or therapeutic target for diagnosis and therapy of breast cancer.

References

No references provided.

Cited by 93 citations (total)

Journal Article Review

The role of microRNAs in human breast cancer progression.

Electronic publication date October 7, 2014

Search for publications in this journal Tumour Biol

WenCheng Zhang [...] Guangshun Wang et al.

Over the past decade, microRNAs (miRNAs) have become a new paradigm of gene regulation. miRNAs are involved in a wide...

Journal Article Review

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action.

Electronic publication date January 23, 2018

Search for publications in this journal Oncotarget

Julien Masliah-Planchon [...] Eric Pasmant et al.

The highly conserved RAS-mitogen activated protein kinase (MAPK) signaling pathway is involved in a wide range of cellular processes including...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

© 2013 FEBS.